Pulse Biosciences, Inc.
PLSE
$20.93
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -23.64% | 47.53% | 82.10% | 99.56% | 102.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.61% | 49.78% | 72.91% | 69.99% | 61.66% |
| Operating Income | 9.91% | -49.15% | -72.91% | -69.99% | -61.66% |
| Income Before Tax | 10.07% | -52.88% | -68.39% | -65.68% | -62.45% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 10.07% | -52.88% | -68.39% | -65.68% | -62.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.07% | -52.88% | -68.39% | -65.68% | -62.45% |
| EBIT | 9.91% | -49.15% | -72.91% | -69.99% | -61.66% |
| EBITDA | 9.91% | -50.52% | -75.03% | -72.17% | -63.33% |
| EPS Basic | 17.67% | -38.58% | -43.09% | -40.96% | -44.16% |
| Normalized Basic EPS | 17.67% | -38.52% | -43.17% | -41.03% | -44.06% |
| EPS Diluted | 17.67% | -38.58% | -43.09% | -40.96% | -44.16% |
| Normalized Diluted EPS | 17.67% | -38.52% | -43.17% | -41.03% | -44.06% |
| Average Basic Shares Outstanding | 9.24% | 10.35% | 17.66% | 17.51% | 12.71% |
| Average Diluted Shares Outstanding | 9.24% | 10.35% | 17.66% | 17.51% | 12.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |